| 1. |
From the Editor |
| |
Inpharma Weekly,
Volume &NA;,
Issue 985,
1995,
Page 2-2
&NA;,
Preview
|
PDF (1179KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 2. |
Meropenem may improve upon current treatments for meningitis |
| |
Inpharma Weekly,
Volume &NA;,
Issue 985,
1995,
Page 3-4
Robert Short,
Jill Stein,
Preview
|
PDF (2101KB)
|
|
摘要:
Studies of meropenem in paediatric meningitis and a number of intra-abdominal infections have indicated that this agent may be a valuable alternative to currently available antibacterials. Following its launch in several European countries, it has become the first injectable carbapenem available for treating meningitis, and the first one that does not require concomitant administration of an enzyme inhibitor. The results of a number of studies of meropenem were presented at the 7th European Congress of Clinical Microbiology and Infectious Diseases [Vienna, Austria; March 1995].
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 3. |
Caution with paediatric sedation cocktail |
| |
Inpharma Weekly,
Volume &NA;,
Issue 985,
1995,
Page 4-4
&NA;,
Preview
|
PDF (1074KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 4. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 985,
1995,
Page 5-5
&NA;,
Preview
|
PDF (996KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 5. |
Should allogeneic BMT recipients be reimmunised? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 985,
1995,
Page 6-6
&NA;,
Preview
|
PDF (1082KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 6. |
CHF guidelines cut therapy costs |
| |
Inpharma Weekly,
Volume &NA;,
Issue 985,
1995,
Page 7-7
&NA;,
Preview
|
PDF (1031KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 7. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 985,
1995,
Page 8-8
&NA;,
Preview
|
PDF (1068KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 8. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 985,
1995,
Page 9-9
&NA;,
Preview
|
PDF (1007KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 9. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 985,
1995,
Page 10-10
&NA;,
Preview
|
PDF (1075KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 10. |
Peptide-based EBV vaccine in phase I trial |
| |
Inpharma Weekly,
Volume &NA;,
Issue 985,
1995,
Page 11-12
Jo Barnes,
Preview
|
PDF (2149KB)
|
|
摘要:
The first clinical study of a synthetic peptide-based vaccine against the Epstein-Barr virus (EBV) is now underway. Researchers are hopeful that the vaccine, which contains a cytotoxic T-lymphocyte (CTL) epitope, may protect against EBV immunopathology.Inpharma®spoke to Dr Andreas Suhrbier, from the Queensland Institute of Medical Research, Brisbane, Australia, about the current phase I trial and the potential applications for an EBV vaccine in protecting against infectious mononucleosis (glandular fever) and the development of post-transplant lymphoproliferative disease (PTLD).
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
首页
